以下部分引用 AI 总结,现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
Lilly
21 atoms · 跨 8 天 · 首见 2026-04-19 · 最近 2026-06-30
三色: 🟦 fact 19 · 🟥 take 2 · stance ▲2/▼1/◆2
来源: X 21
时态: fresh:21
标签: 好数字:14 · 好信源:6 · 好观点:2 · 好思考:1
叙事 (narrative) (2)
- 2026-05-21 · 비만 치료 접근성
더 이상 비만은 질병이 아닐 것입니다. (릴리에게 돈을 지불할 수 있는 사람에 한해)
tags: 好观点·好思考 · → daily
value: direction=제한적
- 2026-06-30 · AI驱动估值潜力
With AI they could easily 10X that valuation.
tags: 好观点 · → daily
value: qty=$10T
事实 (fact) (19)
- 2026-05-22 ⭐ · retatrutide 最高剂量减重效果
highest dose lost 28.3% of body weight in 80 wks
tags: 好数字·好信源 · → daily
value: qty=28.3% · date=80 wks
- 2026-05-26 · 收购CureVac
LILLY TO ACQUIRE CUREVO, LIMMATECH AND VACCINE CO. - WSJ
tags: 好数字 · → daily
- 2026-05-26 · 收购 Curevo, LimmaTech, 疫苗公司
LILLY TO BUY CUREVO, LIMMATECH, VACCINE CO - WSJ
tags: 好信源 · → daily
- 2026-05-26 · 收购CureVac
LILLY TO BUY CUREVO, LIMMATECH BIOLOGICS AND VACCINE CO - WSJ
tags: 好信源 · → daily
- 2026-05-26 · 疫苗交易对价上限
LILLY TO PAY UP TO $1.55B FOR VACCINE CO
tags: 好数字 · → daily
value: qty=$1.55B
- 2026-05-26 · CureVac收购现金对价
LILLY TO PAY UP TO $1.5B IN CASH FOR CUREVO: WSJ
tags: 好数字 · → daily
value: qty=$1.5B
- 2026-05-21 · retatrutide 减重效果
45.3% OF PATIENTS TAKING 12 MG OF RETATRUTIDE FROM ELI LILLY LOST AT LEAST 30% OF THEIR WEIGHT AFTER 80 WEEKS.
tags: 好数字 · → daily
value: qty=45.3% · date=80 weeks
- 2026-04-30 · Q1 2026 revenue growth
we delivered 56% revenue growth in Q1 26
tags: 好数字 · → daily
value: qty=56% · date=Q1 2026
- 2026-04-27 · to buy Ajax Therapeutics for up to $2.38 in cash
LILLY TO BUY AJAX THERAPEUTICS FOR UP TO $2.38 IN CASH
tags: 好数字 · → daily
value: qty=$2.38 · date=2026-04-27
- 2026-04-19 · 收购 Kelonia Therapeutics 谈判
ELI LILLY IS IN ADVANCED NEGOTIATIONS TO ACQUIRE CANCER BIOTECH FIRM KELONIA THERAPEUTICS FOR OVER $2 BILLION. - WSJ
tags: 好信源 · → daily
value: qty=over $2 billion · date=2026-04-19
- 2026-05-31 · retatrutide 三期数据
retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels
tags: 好信源 · → daily
- 2026-05-26 · 收购 Curevo, Limmatech Biologics 和 Vaccine Co
Lilly is reportedly buying Curevo, Limmatech Biologics and Vaccine Co in deals worth about $4 billion combined.
tags: 好数字 · → daily
value: qty=$4 billion · currency=USD
- 2026-05-22 · retatrutide phase 3 最高剂量减重百分比
highest dose lost 28.3% of body weight in 80 wks
tags: 好数字 · → daily
value: qty=28.3% · date=80周
- 2026-05-22 · retatrutide phase 3 平均减重绝对值
70 lbs ave
tags: 好数字 · → daily
value: qty=70 lbs
- 2026-05-22 · retatrutide phase 3 减重≥30%患者比例
45% lost 30% or more of their body weight
tags: 好数字 · → daily
value: qty=45%
- 2026-05-22 · retatrutide phase 3 最高剂量组肥胖缓解率
65% on the top dose no longer clinically obese
tags: 好数字 · → daily
value: qty=65%
- 2026-05-22 · retatrutide 靶点机制
Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively.
tags: 好信源 · → daily
value: qty=3
- 2026-05-22 · retatrutide phase 3 最高剂量副作用及退出率
Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate.
tags: 好数字 · → daily
value: qty=11.3%
- 2026-05-22 · retatrutide phase 3 最低剂量减重效果
The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.
tags: 好数字 · → daily
value: qty=19%
时间轴 (近 20)
- 2026-06-30 ·
narrative · AI驱动估值潜力 · → daily
- 2026-05-31 ·
fact · retatrutide 三期数据 · → daily
- 2026-05-26 ·
fact · 收购CureVac · → daily
- 2026-05-26 ·
fact · 收购 Curevo, LimmaTech, 疫苗公司 · → daily
- 2026-05-26 ·
fact · 收购CureVac · → daily
- 2026-05-26 ·
fact · 疫苗交易对价上限 · → daily
- 2026-05-26 ·
fact · CureVac收购现金对价 · → daily
- 2026-05-26 ·
fact · 收购 Curevo, Limmatech Biologics 和 Vaccine Co · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 最高剂量减重百分比 · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 平均减重绝对值 · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 减重≥30%患者比例 · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 最高剂量组肥胖缓解率 · → daily
- 2026-05-22 ·
fact · retatrutide 靶点机制 · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 最高剂量副作用及退出率 · → daily
- 2026-05-22 ·
fact · retatrutide phase 3 最低剂量减重效果 · → daily
- 2026-05-22 ·
fact · retatrutide 最高剂量减重效果 · → daily
- 2026-05-21 ·
fact · retatrutide 减重效果 · → daily
- 2026-05-21 ·
narrative · 비만 치료 접근성 · → daily
- 2026-04-30 ·
fact · Q1 2026 revenue growth · → daily
- 2026-04-27 ·
fact · to buy Ajax Therapeutics for up to $2.38 in cash · → daily
← 实体目录 · 系统日志